Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Clinical trial NCT02535091 · COMPLETED
Trial details
- NCT number
- NCT02535091
- Sponsor
- SK Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-03
- Primary completion
- 2021-03-31
- Enrollment
- 1345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.